Discovery of 4-[4-({(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl}methyl)phenoxy]benzoic acid hydrochloride: A highly potent orally available CCR5 selective antagonist

Based on the original spirodiketopiperazine design framework, further optimization of an orally available CCR5 antagonist was undertaken. Structural hybridization of the hydroxylated analog 4 derived from one of the oxidative metabolites and the new orally available non-hydroxylated benzoic acid ana...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Bioorg Med Chem
Hlavní autoři: Nishizawa, Rena, Nishiyama, Toshihiko, Hisaichi, Katsuya, Minamoto, Chiaki, Murota, Masayuki, Takaoka, Yoshikazu, Nakai, Hisao, Tada, Hideaki, Sagawa, Kenji, Shibayama, Shiro, Fukushima, Daikichi, Maeda, Kenji, Mitsuya, Hiroaki
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7604827/
https://ncbi.nlm.nih.gov/pubmed/21658961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2011.05.022
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky